Complete characterization of the mutation landscape reveals the effect on amylin stability and amyloidogenicity.

Abstract excerpt

Type-II diabetes is believed to be partially aggravated by the emergence of toxic amylin protein deposits in the extracellular space of the pancreas β-cells. Amylin, the regulatory hormone that is co-secreted with insulin, has been observed to misfold into toxic structures. Pramlintide, an FDA approved injectable amylin analog mutated at positions 25, 28, and 29 was therefore developed to create a more stable,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyloid
• Share to Computational Biology
• Share to Islet Amyloid Polypeptide